D
David J. Gagne
Publications - 15
Citations - 1989
David J. Gagne is an academic researcher. The author has contributed to research in topics: Computer science & Sirtuin 1. The author has an hindex of 4, co-authored 4 publications receiving 1842 citations.
Papers
More filters
Journal ArticleDOI
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne,Philip D. Lambert,Simon Schenk,David P. Carney,J. Joshua Smith,David J. Gagne,Lei Jin,Olivier Boss,Robert B. Perni,Chi B. Vu,Jean Bemis,Roger Xie,Jeremy S. Disch,Pui Yee Ng,Joseph J. Nunes,Amy V. Lynch,Hongying Yang,Heidi Galonek,Kristine Israelian,Wendy Choy,Andre Iffland,Siva Lavu,Oliver Medvedik,David A. Sinclair,Jerrold M. Olefsky,Michael R. Jirousek,Peter J. Elliott,Christoph H. Westphal +27 more
TL;DR: These compounds bind to the SIRT1 enzyme–peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates and improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver.
Journal ArticleDOI
Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo
J. Joshua Smith,Renee Deehan Kenney,David J. Gagne,Brian P. Frushour,William M. Ladd,Heidi Galonek,Kristine Israelian,Jeffrey Song,Giedre Razvadauskaite,Amy V. Lynch,David P. Carney,Robin J Johnson,Siva Lavu,Andre Iffland,Peter J. Elliott,Philip D. Lambert,Keith O. Elliston,Michael R. Jirousek,Jill C. Milne,Olivier Boss +19 more
TL;DR: It is demonstrated that SIRT1 activators recapitulate many of the molecular events downstream of CR in vivo, such as enhancing mitochondrial biogenesis, improving metabolic signaling pathways, and blunting pro-inflammatory pathways in mice fed a high fat, high calorie diet.
Journal ArticleDOI
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
Chi B. Vu,Jean Bemis,Jeremy S. Disch,Pui Yee Ng,Joseph J. Nunes,Jill C. Milne,David P. Carney,Amy V. Lynch,J. Joshua Smith,Siva Lavu,Philip D. Lambert,David J. Gagne,Michael R. Jirousek,Simon Schenk,Jerrold M. Olefsky,Robert B. Perni +15 more
TL;DR: A series of imidazo[1,2-b]thiazole derivatives is shown to activate the NAD(+)-dependent deacetylase SIRT1, a potential new therapeutic target to treat various metabolic disorders.
Journal ArticleDOI
Discovery of benzothiazole derivatives as efficacious and enterocyte-specific MTP inhibitors.
Chi B. Vu,Jill C. Milne,David P. Carney,Jeffrey Song,Wendy Choy,Philip D. Lambert,David J. Gagne,Michael Hirsch,Angela Cote,Meghan Davis,Elden Lainez,Nekeya Meade,Karl D. Normington,Michael R. Jirousek,Robert B. Perni +14 more
TL;DR: A series of triamide derivatives bearing a benzothiazole core is shown to be potent microsomal triglyceride transfer protein (MTP) inhibitors and selected analogs within this series have been demonstrated to reduce food intake along with body weight and thereby improve glucose homeostasis and insulin sensitivity in a 28-day mice diet-induced obesity (DIO) model.
Journal ArticleDOI
Challenges and benchmark datasets for machine learning in the atmospheric sciences: Definition, status and outlook
TL;DR: This paper equips the domain of atmospheric sciences with a recipe for how to build proper benchmark datasets, a (non-exclusive) list of domain specific challenges for machine learning is presented, and it is elaborated where and what benchmark datasets will be needed to tackle these challenges.